Myriad Genetics
MYGN
MYGN
192 hedge funds and large institutions have $943M invested in Myriad Genetics in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 62 increasing their positions, 64 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% less funds holding
Funds holding: 196 → 192 (-4)
14% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 29
Holders
192
Holding in Top 10
1
Calls
$2.59M
Puts
$1.67M
Top Buyers
| 1 | +$13M | |
| 2 | +$12.4M | |
| 3 | +$8.41M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$6.08M |
| 5 |
Two Sigma Advisers
New York
|
+$3.11M |
Top Sellers
| 1 | -$13.6M | |
| 2 | -$7.95M | |
| 3 | -$5.92M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$4.03M |
| 5 |
PA
Pinnacle Associates
New York
|
-$3.83M |